www.actusnews.com

Cybergun - Augmentation de capital 2013

ActusNewsWire - ACTivateur de réputation sur internet
Diffuser vos communiqués de Presse ou vos communiqués financiers (Diffuseur Professionnel d'Information Réglementée autorisé par l’AMF).

Nos offres commerciales

Actusnews - Diffusion internationale Actusnews - Diffusion réglementée Actusnews - Création site web Actusnews - Document interactif Actusnews - Internet influence

Actusnews.com

Informations sur la société
"NATUREX"
Communiqué "NATUREX"
du 06/07/2012 à 18H00

NATUREX

Consulter le site Internet de la société NATUREX

NATUREX

Number of shares and voting rights as at 30th June 2012

Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)

30.06.2012

Total number of outstanding shares forming the capital
- 6,953,900 ordinary shares under ISIN FR0000054694
- 757, 308 preferred shares under ISIN FR0010833251
 
 
7,711,208
Total number of outstanding shares forming the capital with voting rights
- 6,953,768 ordinary shares under ISIN FR0000054694
- 132 ordinary shares arising from exercise of options
 
6,953,900
Number of shares with double voting rights 215,843
Total number of gross voting rights 7,169,743
 
Number of shares without voting rights
- 12,028 bearer shares in the frame of the liquidity contract
 
 
- 12,028
Total number of exercisable voting rights*  7,157,715

*Real number of voting rights = total number of voting rights – number of shares without voting rights

If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com

Naturex has been listed since October 1996 on NYSE Euronext Paris, Compartment B (MidCaps)

Number of shares comprising the capital: 7,711,208

  • 6,953,900 ordinary shares (ISIN FR0000054694)
  • 757,308 preferred shares (ISIN FR0010833251)

Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex has implemented a Sponsored Level I American Depositary Receipt (ADR) program,
which trades on over-the-counter market in the United States under symbol NTUXY.

TICKER: NRX - Reuters : NATU.PA - Bloomberg : NRX:FP - DR Symbol: NTUXY

About Naturex

NATUREX is a global leader in specialty plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

NATUREX's head office is based in Avignon, France. The company employs more than 1,200 people with high-performance manufacturing operations across 16 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland), as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 21 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).

NATUREX's development is supported by positive underlying trends linked to a fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.

Contacts  
 
Thierry Lambert
Vice-President and CEO
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com
 
 
 
 
 
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
 
Tous les communiqués
"NATUREX"
Haut de page  Consulter le communiqué de la société NATUREX du 06/07/2012 à 18H00 au format PDF :
Number of shares and voting rights as at 30th June 2012
PDF 205Ko
  Imprimer ce communiqué
Cet e-mail est protégé contre les robots collecteurs de mails, votre navigateur doit accepter le Javascript pour le voir   -   Avertissement légal
© 2000-2013 actusnews.com®.
Tous droits réservés.